Ontology highlight
ABSTRACT:
SUBMITTER: Mistry AM
PROVIDER: S-EPMC10755919 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Frontiers in oncology 20231214
Dexamethasone has been commonly given to patients with a presumed new GBM in relatively large doses (6-16 mg daily for 1-2 weeks) since the 1960s without any rigorous evidence. This treatment with dexamethasone before the diagnosis and adjuvant therapy makes GBM patients unique compared to other newly diagnosed cancer patients. While dexamethasone may be beneficial, recent studies suggest that this potent immunosuppressant with pleiotropic effects is harmful in the long term. This perspective ar ...[more]